No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹384.9Prev. Close
₹384.05Turnover(Lac.)
₹79.99Day's High
₹387Day's Low
₹37752 Week's High
₹47952 Week's Low
₹225.05Book Value
₹27.08Face Value
₹1Mkt Cap (₹ Cr.)
4,154.85P/E
90.05EPS
4.28Divi. Yield
0.17No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 10.9 | 7.26 | 7.26 | 7.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 237.49 | 194.11 | 141.88 | 96.06 |
Net Worth | 248.39 | 201.37 | 149.14 | 103.32 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 90.56 | 85.12 | 38.79 | 35.69 |
yoy growth (%) | 6.38 | 119.39 | 8.7 | 9.4 |
Raw materials | -15.37 | -11.33 | -2.15 | -1.48 |
As % of sales | 16.97 | 13.31 | 5.55 | 4.16 |
Employee costs | -7.11 | -6.43 | -4.45 | -4.41 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 40.88 | 31.25 | 4.83 | 4.88 |
Depreciation | -1.73 | -1.36 | -1.14 | -1.11 |
Tax paid | -10.7 | -7.58 | -0.97 | -0.5 |
Working capital | 34.58 | 16.25 | 0.88 | 3.46 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.38 | 119.39 | 8.7 | 9.4 |
Op profit growth | 26.67 | 410.27 | 3.15 | -0.1 |
EBIT growth | 30.09 | 512.27 | -0.7 | 5.32 |
Net profit growth | 27.47 | 512.18 | -11.65 | -5.44 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,786.4 | 142.85 | 4,28,785.15 | 608.7 | 0.9 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638.5 | 66.2 | 1,76,241.94 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,463.7 | 68.28 | 1,51,058.35 | 467 | 0.85 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,377 | 32.3 | 1,11,179.71 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,098.3 | 29.92 | 1,10,474.43 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Dinesh S Patel
Managing Director
Sachin D Patel
Independent Non Exe. Director
Kirandeep Madan
Independent Non Exe. Director
Hitesh Dharmasinh Gajaria
Independent Non Exe. Director
K G Ananthakrishnan
Independent Director
NIHAR AJAY PARIKH
Additional Director
Rajneesh Anand
69/C GIDC Industrial Estate,
Valsad Dist,
Gujarat - 396195
Tel: 91-260-2430027
Website: http://www.gtbl.in
Email: gtblmumbai@gtbl.in; admin@gtbl.co.in
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The...
Read More
Reports by Gujarat Themis Biosyn Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.